These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 16541305
1. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. McCann SE, Kulkarni S, Trevisan M, Vito D, Nie J, Edge SB, Muti P, Freudenheim JL. Breast Cancer Res Treat; 2006 Oct; 99(3):309-11. PubMed ID: 16541305 [Abstract] [Full Text] [Related]
2. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada). Cotterchio M, Boucher BA, Kreiger N, Mills CA, Thompson LU. Cancer Causes Control; 2008 Apr; 19(3):259-72. PubMed ID: 17992574 [Abstract] [Full Text] [Related]
3. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Touillaud MS, Pillow PC, Jakovljevic J, Bondy ML, Singletary SE, Li D, Chang S. Nutr Cancer; 2005 Apr; 51(2):162-9. PubMed ID: 15860438 [Abstract] [Full Text] [Related]
4. Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status. Zhang M, Yang H, Holman CD. Breast Cancer Res Treat; 2009 Dec; 118(3):553-63. PubMed ID: 19252980 [Abstract] [Full Text] [Related]
5. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. Touillaud MS, Thiébaut AC, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F. J Natl Cancer Inst; 2007 Mar 21; 99(6):475-86. PubMed ID: 17374837 [Abstract] [Full Text] [Related]
6. Dietary mushroom intake and the risk of breast cancer based on hormone receptor status. Shin A, Kim J, Lim SY, Kim G, Sung MK, Lee ES, Ro J. Nutr Cancer; 2010 Mar 21; 62(4):476-83. PubMed ID: 20432168 [Abstract] [Full Text] [Related]
7. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Pietinen P, Stumpf K, Männistö S, Kataja V, Uusitupa M, Adlercreutz H. Cancer Epidemiol Biomarkers Prev; 2001 Apr 21; 10(4):339-44. PubMed ID: 11319174 [Abstract] [Full Text] [Related]
8. Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. McCann SE, Muti P, Vito D, Edge SB, Trevisan M, Freudenheim JL. Int J Cancer; 2004 Sep 01; 111(3):440-3. PubMed ID: 15221974 [Abstract] [Full Text] [Related]
9. Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Piller R, Chang-Claude J, Linseisen J. Eur J Cancer Prev; 2006 Jun 01; 15(3):225-32. PubMed ID: 16679865 [Abstract] [Full Text] [Related]
10. The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case-control study. Zaineddin AK, Buck K, Vrieling A, Heinz J, Flesch-Janys D, Linseisen J, Chang-Claude J. Nutr Cancer; 2012 Jun 01; 64(5):652-65. PubMed ID: 22591208 [Abstract] [Full Text] [Related]
11. Predicting risk of breast cancer in postmenopausal women by hormone receptor status. Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA, Women's Health Initiative Investigators. J Natl Cancer Inst; 2007 Nov 21; 99(22):1695-705. PubMed ID: 18000216 [Abstract] [Full Text] [Related]
12. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women. Anderson LN, Cotterchio M, Boucher BA, Kreiger N. Int J Cancer; 2013 Apr 01; 132(7):1683-92. PubMed ID: 22907507 [Abstract] [Full Text] [Related]
13. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women. Zeleniuch-Jacquotte A, Toniolo P, Levitz M, Shore RE, Koenig KL, Banerjee S, Strax P, Pasternack BS. Cancer Epidemiol Biomarkers Prev; 1995 Dec 01; 4(8):857-60. PubMed ID: 8634657 [Abstract] [Full Text] [Related]
14. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study. Sonestedt E, Borgquist S, Ericson U, Gullberg B, Olsson H, Adlercreutz H, Landberg G, Wirfält E. Cancer Epidemiol Biomarkers Prev; 2008 Nov 01; 17(11):3241-51. PubMed ID: 18990767 [Abstract] [Full Text] [Related]
15. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. Hedelin M, Bälter KA, Chang ET, Bellocco R, Klint A, Johansson JE, Wiklund F, Thellenberg-Karlsson C, Adami HO, Grönberg H. Prostate; 2006 Oct 01; 66(14):1512-20. PubMed ID: 16921512 [Abstract] [Full Text] [Related]
16. Carbohydrates and the risk of breast cancer among Mexican women. Romieu I, Lazcano-Ponce E, Sanchez-Zamorano LM, Willett W, Hernandez-Avila M. Cancer Epidemiol Biomarkers Prev; 2004 Aug 01; 13(8):1283-9. PubMed ID: 15298947 [Abstract] [Full Text] [Related]
17. Plasma enterolactone and breast cancer incidence by estrogen receptor status. Olsen A, Knudsen KE, Thomsen BL, Loft S, Stripp C, Overvad K, Møller S, Tjønneland A. Cancer Epidemiol Biomarkers Prev; 2004 Dec 01; 13(12):2084-9. PubMed ID: 15598765 [Abstract] [Full Text] [Related]
18. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study. Deandrea S, Talamini R, Foschi R, Montella M, Dal Maso L, Falcini F, La Vecchia C, Franceschi S, Negri E. Cancer Epidemiol Biomarkers Prev; 2008 Aug 01; 17(8):2025-8. PubMed ID: 18708394 [Abstract] [Full Text] [Related]
19. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, Cheng J, Gao YT, Zheng W. Cancer Epidemiol Biomarkers Prev; 2002 Sep 01; 11(9):815-21. PubMed ID: 12223424 [Abstract] [Full Text] [Related]
20. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C. Cancer Epidemiol Biomarkers Prev; 2006 Dec 01; 15(12):2482-8. PubMed ID: 17164374 [Abstract] [Full Text] [Related] Page: [Next] [New Search]